Improving physical activity in men with prostate cancer through wearable devices and online education: Randomized controlled trial.

Int J Med InformMay 19, 2026 (epub)
Clinical ResearchOncology (Medical)

Meagan O'Neill, Catherine M Sabiston, George Tomlinson et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial evaluated the feasibility of technology-based interventions, specifically wearable devices and online education, to reduce sedentary behavior and improve cancer-related fatigue in men with prostate cancer. Among 21 participants, trends indicated that those using wearable devices experienced a reduction in fatigue, with an average effect of 3.8 on the FACT-F scale.

Key findings

  • Consent rate was 12.1% with 28 out of 231 approached participants agreeing to join.
  • Retention rate was 52.4%, with 11 out of 21 participants completing the study.
  • Average effect on fatigue (FACT-F) was 3.8 for WEAR and -1.1 for EDU.
  • Moderate intervention adherence was observed at 60% among participants.

Why it matters

Understanding the feasibility of technology-based interventions can help clinicians identify effective strategies to support physical activity and manage cancer-related fatigue in prostate cancer survivors, ultimately improving their quality of life.

Source

PubMed · PMID 42176601

Published in Int J Med Inform. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Clinical ResearchVascular SurgeryOpen access

Revascularization of Asymptomatic Carotid Artery Stenosis: Cognitive Results of the CREST-2 Randomized Trials.

This prespecified cognitive-outcomes analysis of the multicentre, randomised CREST-2 trials assessed patients aged 35 years or older with at least 70% asymptomatic carotid stenosis.

JAMAOct 27, 2026Read summary
Clinical ResearchObstetrics & GynecologyOpen access

Intrauterine Mepivacaine Instillation vs Placebo for Pain During IUD Placement: A Randomized Clinical Trial.

This multicentre, double-blind, randomised, placebo-controlled trial tested intrauterine mepivacaine before IUD placement in nulliparous individuals aged 18 to 31 years at 11 Swedish clinics.

JAMAOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.